BIAF
NASDAQ · Biotechnology
Bioaffinity Technologies Inc
$0.85
+0.10 (+13.49%)
Open$0.72
Previous Close$0.75
Day High$0.90
Day Low$0.72
52W High$28.80
52W Low$18.12
Volume—
Avg Volume437.8K
Market Cap3.83M
P/E Ratio30.93
EPS$0.81
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+3,235.3% upside
Current
$0.85
$0.85
Target
$28.39
$28.39
$22.24
$28.39 avg
$33.42
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 608.9K | 644.1K | 622.1K |
| Net Income | -195,635 | -204,930 | -154,699 |
| Profit Margin | -32.1% | -31.8% | -24.9% |
| EBITDA | -176,028 | -183,952 | -197,812 |
| Free Cash Flow | -119,784 | -113,422 | -103,605 |
| Rev Growth | +18.5% | +20.2% | +21.8% |
| Debt/Equity | 1.28 | 1.08 | 1.14 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |